Mechanism for the delayed elimination of SN-38 in cancer patients with severe renal failure and optimal treatment strategy
Mechanism for the delayed elimination of SN-38 in cancer patients with severe renal failure and optimal treatment strategy
批准号:
23590198
负责人:
FUJITA Ken-ichi
金额:
$3.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013
中文摘要
我们首次证明,尿毒症毒素如CMPF在临床相关浓度下抑制人肝细胞中的SN-38摄取。OATP 1B 1是人肝细胞中SN-38饱和摄取的主要贡献者。尿毒症血浆可下调SLCO 1B 1基因的表达。尿毒症毒素对OATP 1B 1介导的SN-38摄取的抑制和SLCO 1B 1基因表达的下调可能是导致重度肾功能不全患者中观察到的SN-38消除延迟的部分机制。
英文摘要
We have shown for the first time that uremic toxins such as CMPF inhibit SN-38 uptake in human hepatocytes at clinically relevant concentrations. OATP1B1 is a major contributor to the saturable uptake of SN-38 in human hepatocytes. The gene expression of SLCO1B1 was down-regulated by uremic plasma. The inhibition by uremic toxins of OATP1B1-mediated SN-38 uptake and the down-regulated SLCO1B1 gene expressions may be part of the mechanisms causing the delay of SN-38 elimination observed in patients with severe renal dysfunction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Partial inhibition by uremic toxins of hepatic uptake of an active metabolites SN-38 of irinotecan in humans
尿毒症毒素部分抑制人体肝脏摄取伊立替康活性代谢物 SN-38
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[Fujita K, Sugiura T, Nakamichi N, Akiyama Y, Sasaki Y, Kato Y]
通讯作者:
Kato Y
Down-regulation by uremic plasma components of hepatic uptake transporter for SN-38 in humans
人类尿毒症血浆成分对 SN-38 的肝摄取转运蛋白的下调
DOI:
--
发表时间:
2013
期刊:
影响因子:
--
作者:
[Fujita K, Nakamichi N, Sunakawa Y, Shimada K, Kawara K, Sasaki Y, Kato Y]
通讯作者:
Kato Y
Involvement of OATP and inhibition by uremic toxins in hepatic uptake of an anticancer agent SN-38 in humans
OATP 和尿毒症毒素抑制参与人类抗癌剂 SN-38 的肝脏摄取
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[Sugiura T, Fujita K, Okumura H, Umeda S, Nakamichi N, Sasaki Y, Kato Y]
通讯作者:
Kato Y
Optimization of cancer chemotherapy on the basis of pharmacokinetics and pharmacodynamics: from patients enrolled in clinical trials to those in the 'real world'.
基于药代动力学和药效学优化癌症化疗:从参加临床试验的患者到“现实世界”中的患者。
DOI:
--
发表时间:
2014
期刊:
Drug Metabolism and Pharmacokinetics
影响因子:
2.1
作者:
[Ken, Y. Sasaki]
通讯作者:
Y. Sasaki
腎機能障害がん患者におけるイリノテカン塩酸塩の特異な体内動態
盐酸伊立替康在肾功能不全的癌症患者中独特的药代动力学
DOI:
--
发表时间:
2013
期刊:
シスプラチンによる腎機能障害のメカニズム月刊薬事
影响因子:
--
作者:
[池田 龍二, 田實裕介, 西澤由紀彦, 冨山成章, 俣木博徳, 山田勝士, 武田泰生, 藤田健一]
通讯作者:
藤田健一
共 16 条
Efficient Hydrogen Production from Renewable Natural Organic Resources Under Mild Conditions
-
批准号:26620153
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2014
-
负责人:FUJITA Ken-ichi
-
依托单位:
Involvement of calcium signal in gene regulation related to drug exhaust
-
批准号:25460128
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2013
-
负责人:FUJITA Ken-ichi
-
依托单位:
Development of novel recyclable homogeneous metal complex catalysts
-
批准号:23550183
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:FUJITA Ken-ichi
-
依托单位:
Development of Oxidant-Free Oxidation of Alcohols Catalyzed by Group 9 Metal Complexes and their Application to Organic Synthesis
-
批准号:19750075
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.36万
-
财政年份:2007
-
负责人:FUJITA Ken-ichi
-
依托单位:
Factors causing interindividual variability in response to morphine
-
批准号:19590542
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:FUJITA Ken-ichi
-
依托单位:
Analysis of tubulin metabolisms in fungi
-
批准号:18580081
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.47万
-
财政年份:2006
-
负责人:FUJITA Ken-ichi
-
依托单位:
Development of micelle-like catalyst for aqueous-media organic synthesis
-
批准号:17550147
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2005
-
负责人:FUJITA Ken-ichi
-
依托单位:
海外基金